Project 2 final

profilenteasley
P2Policylaw.docx

Health Policy Project 2:

Precious Teasley

Southern New Hampshire University

Health Policy and Law 22TW5

Dr. Jim Dockins

July 21,2022

Health Policy Project 2: Continuation

Stakeholder Needs

Low compensation for immunization services is a problem for physicians, so the government must ensure that they are reimbursed adequately. Immunizations are too costly for vulnerable populations whose medical insurance does not cover them. Due to the exorbitant expense of these vaccines in private hospitals and pharmacies, these individuals cannot access them. Adult vaccines may also be unavailable due to the inability of the most vulnerable individuals to travel to distant public health centers in quest of vaccinations. For doctors and pharmacists to purchase vaccines from pharmaceutical companies, a large amount of funds is necessary. In addition, they require funding for the purchase of new, high-tech storage facilities, as the preservation of vaccines requires the usage of specific substances. Pharmaceutical businesses need funding for disease-related research and the installation of intricate systems for creating and monitoring vaccinations. In addition, they need cash to purchase huge, specialized storage containers so that vaccines are accessible everywhere. To provide vaccines to the public, health insurance companies require funding to meet the vaccine administration needs of their consumers. 

Taking the financial demands of stakeholders into account when making decisions about low adult immunization rates can assist assure optimal vaccine supply and distribution, enhanced following and monitoring requirements, and vaccine availability. Consideration of the requests will result in shared provider contacts and public-private partnerships, which will speed up adult immunization.

Financial Influence

The primary financial stakeholders are pharmaceutical corporations, which conducted the research, developed the vaccines, and brought them to market. The patient's financial situation is gently adjusted despite the moral obligation of pharmaceutical companies to ensure that the market can afford their product; the patient, as the product's recipient, experiences hidden impacts. It is essential to be aware of these elements in order to develop an effective health policy. If the underlying reasons for the problem are not addressed, it is impossible to find a remedy. The role of government is to ensure equality for all citizens while safeguarding commercial interests. Before the government can assist the poor with their health issues, it must decide who controls prices and costs (Chaudhary et al., 2020). During the planning and decision-making process, not only the patient and doctors but also the company must be protected and assisted.

Benefits and Disadvantages

In numerous ways, the issue is advantageous to the stakeholders. They will be able to get monies quickly from prom commitments made in the face of emergency illness epidemics to purchase commodities such as drugs, technology, or bednets, which was portrayed as an incentive for R&D. They will be able to fund disease eradication efforts while safeguarding the enterprises that produce the commodities. Sadly, they will also have to deal with challenges such as expensive end phases and lengthy phases, such as when terminating programs. They will be able to enhance the living conditions and economic security of the population that is underserved and marginalized.

Competing Value Conflicts

Each year, thousands of people die in the United States and around the world from vaccine-preventable diseases, placing a major financial drain on healthcare systems. Adult immunization rates in the United States are low, with significant gaps between national adult immunization targets and actual adult immunization rates. This is despite the fact that immunization is one of the most effective primary preventative treatments for enhancing health and well-being. To close these gaps, national leaders must commit to a multifaceted national strategy that includes: ensuring fair and appropriate payment for adult immunization, improving access to recommended adult vaccines by improving the infrastructure for adult vaccines in the United States, and establishing public-private partnerships to support effective immunization behaviors. In terms of low adult immunization rates, numerous other nations face many of the same issues as the United States. Successful methods for adult vaccination coverage will reduce morbidity, death, and healthcare costs. To realize the great health advantages of an efficient adult immunization program, all medical and public health stakeholders must now collaborate.

Vaccinations, on the other hand, are vital to the health of both the person and the community. Vaccines aid in preventing the spread of infectious, lethal, and severe diseases. They include HPV, measles, polio, mumps, chicken pox, and whooping cough, among others. Vaccination against smallpox was the first to be developed. The present coronavirus (COVID-19) epidemic affects people's health, as well as their ability to learn, work, and live normally. How to alter a school-based educational system is one of the most serious concerns addressed by COVID-19. At its peak, 188 or more countries, or over 91% of all enrolled children worldwide, stopped their schools in an effort to stop the spread of the virus (Di Pietro et al., 2020). All kids are significantly affected by school closures, but the most vulnerable are disproportionately affected because they are more likely to face additional obstacles. Children and adolescents with special educational needs, low-income and single-parent households, immigrants, refugees, members of ethnic minorities, and Indigenous peoples share these features. Some do not have access to hands-on learning activities, social and emotional assistance in the classroom, and supplementary programs like school dinners.

They run the risk of falling further behind and isolating themselves with the classroom doors shut. These pupils are likely to suffer the most in terms of educational success and school support if governments do not take enough measures to promote educational fairness and inclusion. The subsequent sections provide an overview of the actions made by OECD Member Countries to address the different needs of pupils at risk during the COVID-19 outbreak. This Policy Brief investigates the issue of school reopenings, reviews nations' current actions, and offers policy recommendations to ensure that the epidemic does not prevent poor pupils from participating in educational institutions.

References

Chaudhary, M., Sodani, P. R., & Das, S. (2020). Effect of COVID-19 on the economy in India: Some reflections for policy and program. Journal of Health Management22(2), 169-180. https://doi.org/10.1177%2F0972063420935541

Di Pietro, G., Biagi, F., Costa, P., Karpiński, Z., & Mazza, J. (2020). The likely impact of COVID-19 on education: Reflections based on the existing literature and recent international datasets (Vol. 30275). Luxembourg: Publications Office of the European Union.